I'm all for the David vs Golaith story, I really am. But building it to get to 'BP' status takes a TON of time and a ton of resources. I think you hit it on the head when he's suggested multiple times 3 digits (and yesterday err 3/1 that it was conservative) it was meant for a suitor, not shareholder. Maybe the suitor will meet halfway at 50b? Possible as BMS/Celgene was a nice M&A for 79B. 50B would be pennies on the dollar for a molecule that, IMHO that can do it all.